Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03960840
Title CD19-specific CAR-T Cells in CLL/SLL and DLBCL
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Novartis Pharmaceuticals

chronic lymphocytic leukemia/small lymphocytic lymphoma

chronic lymphocytic leukemia

diffuse large B-cell lymphoma


Ibrutinib + YTB323


Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | AUT

No variant requirements are available.